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Understanding the α-crystallin cell membrane conjunction 
Abstract 
PURPOSE. It is well established that levels of soluble α-crystallin in the lens cytoplasm fall steadily with 
age, accompanied by a corresponding increase in the amount of membrane-bound α-crystallin. Less well 
understood, is the mechanism driving this age-dependent membrane association. The aim of this study 
was to investigate the role of the membrane and its associated proteins and peptides in the binding of α-
crystallin. 
METHODS. Fibre cell membranes from human and bovine lenses were separated from soluble proteins by 
centrifugation. Membranes were stripped of associated proteins with successive aqueous, urea and 
alkaline solutions. Protein constituents of the respective membrane isolates were examined by SDS-PAGE 
and Western immunoblotting. Recombinant αA- and αB-crystallins were fluorescently-labeled with 
Alexa350® dye and incubated with the membrane isolates and the binding capacity of membrane for α-
crystallin was determined. 
RESULTS. The binding capacity of human membranes was consistently higher than that of bovine 
membranes. Urea- and alkali-treated membranes from the nucleus had similar binding capacities for αA-
crystallin, which were significantly higher than both cortical membrane extracts. αB-Crystallin also had a 
higher affinity for nuclear membrane. However, urea-treated nuclear membrane had three times the 
binding capacity for αB-crystallin as compared to the alkali-treated nuclear membrane. Modulation of the 
membrane-crystallin interaction was achieved by the inclusion of an N-terminal peptide of αB-crystallin in 
the assays, which significantly increased the binding. Remarkably, following extraction with alkali, full 
length αA- and αB-crystallins were found to remain associated with both bovine and human lens 
membranes. 
CONCLUSIONS. Fiber cell membrane isolated from the lens has an inherent capacity to bind α-crystallin. 
For αB-crystallin, this binding was found to be proportional to the level of extrinsic membrane proteins in 
cells isolated from the lens nucleus, indicating these proteins may play a role in the recruitment of αB-
crystallin. No such relationship was evident for αA-crystallin in the nucleus, or for cortical membrane 
binding. Intrinsic lens peptides, which increase in abundance with age, may also function to modulate the 
interaction between soluble α-crystallin and the membrane. In addition, the tight association between α-
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PURPOSE. It is well established that levels of soluble α-crystallin in the lens cytoplasm fall steadily 
with age, accompanied by a corresponding increase in the amount of membrane-bound α-crystallin. 
Less well understood, is the mechanism driving this age-dependent membrane association. The aim 
of this study was to investigate the role of the membrane and its associated proteins and peptides in 
the binding of α-crystallin.  
METHODS. Fibre cell membranes from human and bovine lenses were separated from soluble 
proteins by centrifugation. Membranes were stripped of associated proteins with successive aqueous, 
urea and alkaline solutions. Protein constituents of the respective membrane isolates were examined 
by SDS-PAGE and Western immunoblotting. Recombinant αA- and αB-crystallins were 
fluorescently-labeled with Alexa350® dye and incubated with the membrane isolates and the 
binding capacity of membrane for α-crystallin was determined.  
RESULTS. The binding capacity of human membranes was consistently higher than that of bovine 
membranes. Urea- and alkali-treated membranes from the nucleus had similar binding capacities for 
αA-crystallin, which were significantly higher than both cortical membrane extracts. αB-Crystallin 
also had a higher affinity for nuclear membrane. However, urea-treated nuclear membrane had three 
times the binding capacity for αB-crystallin as compared to the alkali-treated nuclear membrane. 
Modulation of the membrane-crystallin interaction was achieved by the inclusion of an N-terminal 
peptide of αB-crystallin in the assays, which significantly increased the binding. Remarkably, 
following extraction with alkali, full length αA- and αB-crystallins were found to remain associated 
with both bovine and human lens membranes.  
CONCLUSIONS. Fiber cell membrane isolated from the lens has an inherent capacity to bind 
α-crystallin. For αB-crystallin, this binding was found to be proportional to the level of extrinsic 
membrane proteins in cells isolated from the lens nucleus, indicating these proteins may play a role 
in the recruitment of αB-crystallin. No such relationship was evident for αA-crystallin in the 
nucleus, or for cortical membrane binding. Intrinsic lens peptides, which increase in abundance with 
age, may also function to modulate the interaction between soluble α-crystallin and the membrane. 
In addition, the tight association between α-crystallin and the lens membrane suggests that the 





The human lens grows continuously throughout life via the addition of new fibre cells on top of 
preexisting ones. This process leads to the formation of two lens regions referred to as the nucleus, 
consisting of fibre cells formed in utero, and an ever-expanding cortex which consists of fibre cells 
formed post-natally [1, 2]. Lens fibre cells contain a high concentration of the structural proteins α-, 
β- and γ-crystallins, which contribute significantly to the transparent and refractive properties of the 
lens. α-Crystallin, which is composed of subunits αA and αB, functions additionally as a molecular 
chaperone [3, 4]. As there is little to no protein turnover in mature lens fibre cells [5], the long-term 
transparency of the lens is dependent on the ability of α-crystallin to sequester unfolded proteins and 
maintain them in soluble chaperone-client complexes. 
 
Lens proteins undergo a multitude of posttranslational modifications during aging, which over time 
contribute to the unfolding and denaturation of crystallins [6-12]. With age, the level of unfolded 
proteins eventually exceeds the chaperone capacity of α-crystallin in the lens, such that by 40 years, 
all free α-crystallin in the lens has been utilized [13-15]. Subsequently, the level of water-insoluble 
and high molecular weight crystallin aggregates in the lens increases significantly [16-19]. 
Large-scale binding of α-crystallin to lens membranes has also been documented in the lens with age 
[20-22], and this has been hypothesized to contribute to the development of nuclear cataract by 
occluding membrane pores, thus leading to the formation of a barrier to diffusion [22-24]. 
 
The association between crystallins and lens fibre cell membranes is believed to be an important 
process by which crystallin insolubilization occurs in the aging lens [22, 25, 26]. Chandrasekher and 
Cenedella [25] showed that essentially all water-insoluble crystallins in old human lenses are 
membrane-bound. α-Crystallin, in particular, has a strong affinity towards lens membrane [20, 21, 
27-30], leading to the suggestion that the overall increase in the membrane binding of crystallins in 
the lens is due to other crystallins associating with membrane-bound α-crystallin [27]. However, little 
is currently known about the mechanism(s) by which α-crystallin associates with the cellular 
membrane, and how age-related changes to the membrane compositions may affect 
crystallin-binding. 
 
In this study, we examined the protein constituents of bovine and human lens membranes after 
successive removal of extrinsic protein. We report the effects of residual membrane-associated 
proteins on the binding behavior of recombinant α-crystallin and the effect upon this binding of a 




Isolation of bovine and human lens fibre cell membranes 
 
A total of 142 human lenses, aged between 54-84 years, were obtained from donors at the Lions New 
South Wales Eye Bank (Sydney, Australia). Tissue was handled in accordance with the tenets of the 
Declaration of Helsinki. Fresh bovine lenses were obtained from a local abattoir. All lenses were 
stored at -80 °C prior to dissection.  
 
Lenses were separated into cortical and nuclear regions using a 4.5 mm diameter trephine. A cold 
scalpel was used to remove 1 mm of tissue from each end of the resulting cylindrical center (nucleus). 
The cortical and nuclear tissues from human lenses and the cortical tissues from the bovine lenses 
were used in this study. Lens membranes were obtained using methods published by Russell et al. [31] 
with minor modifications. Briefly, lens tissues were homogenized in 7 times (w/w) of buffer A (50 
mM Tris-HCl, 5 mM EDTA, 10 mM β-mercaptoethanol, 0.2% sodium azide, pH 7.4) and incubated 
at room temperature for 10 minutes. The homogenate was centrifuged at 15000 × g for 20 minutes at 
4 °C, and the supernatant was discarded. The pellet was re-homogenized in buffer A and centrifuged 
at 15000 × g for another 20 minutes. The resulting pellet was washed with water (MilliQTM), 
centrifuged and re-homogenized in buffer B (50 mM Tris-HCl, 7 M urea, pH 7.4). The urea 
concentration in the homogenate was diluted to 3.5 M with water and the homogenate was 
centrifuged at 15000 × g for 20 minutes. This extraction procedure using buffer B was repeated and 
the resulting pellet was washed three times with water to give the urea-treated membrane. To obtain 
the alkali-treated membrane, a portion of the urea-treated membrane pellet was re-homogenized in 
solution containing 0.1 M NaOH, 1 mM β-mercaptoethanol. The homogenate was incubated on ice 
for 15 minutes and then centrifuged at 15000 × g for 20 minutes at 4 °C. The pellet was further 
washed with 5 mM phosphate (pH 8.0), followed by two washes with water. 
 
Isolated membranes were re-suspended in binding buffer (137 mM NaCl, 2.7 mM KCl, 4.3 mM 
Na2HPO4, 1.4 mM K2HPO4, 5 mM MgCl2, pH 7.3). Quantification of membrane samples was 
achieved by weighing freeze-dried aliquots of the membrane suspension using an Excellence XS105 
dual-range analytical balance (Mettler Toledo, Switzerland). The concentration of membrane tissue 
(mg/ml) in the suspension was calculated by averaging at least four separate aliquots. Light 
absorbance of membrane samples at different wavelengths (220-850 nm) was measured using a 
POLARstar Omega multifunction microplate reader (BMG Labtech, Offenburg, Germany).  
 
SDS-PAGE and Western immunoblot analysis of bovine and human lens membranes 
 
Proteins in the bovine and human lens membrane preparations were examined using SDS-PAGE and 
Western immunoblots. Samples were homogenized in SDS-PAGE loading buffer (60 mM Tris-HCl, 
1% SDS, 1% β-mercaptoethanol, 10% glycerol, 0.01% bromophenol blue, pH 6.8) and incubated at 
room temperature for 2 h prior to loading onto 12% SDS-PAGE gels. Heating of the sample was 
avoided as elevated temperatures can damage the structure of intrinsic membrane proteins [31]. All 
SDS-PAGE gels were stained with Coomassie Blue R (Sigma-Aldrich, St. Louis, Missouri, USA). 
For Western immunoblot analysis, antibodies which specifically recognize human and bovine filensin, 
phakinin, αA- and αB-crystallins were used and were diluted to their working concentrations using 
PBS/T (137 mM NaCl, 2.7 mM KCl, 12.5 mM Na2HPO4, 1.8 mM KH2PO4, 0.05% (v/v) Tween 20, 
pH 7.4) containing 0.5% (w/v) skim milk powder. Proteins separated by SDS-PAGE were transferred 
onto polyvinylidene fluoride membranes at 30 V overnight at 4 °C using the Mini Trans-Blot system 
(Bio-Rad, Hercules, California, USA). Membranes were blocked for 1 h at room temperature in 
PBS/T containing 5% (w/v) skim milk powder. After three 10 min washes with PBS/T, the 
membranes were incubated with either a 1:1000 dilution of polyclonal anti-αA-crystallin antibody 
(ab69552, Abcam, Cambridge, Massachusetts, USA), a 1:1000 dilution of polyclonal 
anti-αB-crystallin antibody (ab13497, Abcam), a 1:1500 dilution of monoclonal anti-filensin 
antibody (F1043, Sigma-Aldrich), or a 1:5000 dilution of monoclonal anti-vimentin antibody (V6389, 
Sigma-Aldrich) for 90 min at room temperature. Following another three 10 min washes with PBS/T, 
the membranes were incubated for 1 h with a 1:1500 dilution of anti-rabbit immunoglobulin G (IgG) 
horseradish peroxidase (HRP) conjugate (65-6120, Invitrogen, Carlsbad, California, USA) for 
anti-αA-crystallin and anti-αB-crystallin blots, or a 1:2500 dilution of goat anti-mouse IgG HRP 
conjugate (SAB-100J, Stressgen, Ann Arbor, Michigan, USA) for anti-filensin and anti-vimentin 
blots. Excess secondary antibodies were removed by three 10 min washes with PBS/T, and the blots 
were developed in 100 mM Tris-HCl (pH 7.6) containing 1.4 mM diaminobenzidine and 0.015% (v/v) 
hydrogen peroxide. 
 
Quantification of phospholipids 
 
Phospholipids were quantified by mass spectrometry as described previously [32]. To identify each 
phospholipid, a combination of precursor and neutral loss scans were used to detect the head-group of 
each phospholipid class [33]. Each phospholipid class was quantified by comparing their peak areas 
with the appropriate internal standard after correction for isotope contributions [32]. The percentage 
of each phospholipid was than determined by its contribution to the total phospholipid.  
 
Overexpression and purification of recombinant human αA- and αB-crystallins 
 
The pET23d(+) plasmid, containing human wild-type αA-crystallin gene, was a gift from Prof. J. M. 
Petrash (Washington University, St. Louis, USA). The pET24d(+) plasmid (Novagen, Madison, 
Wisconsin, USA), containing human wild-type αB-crystallin gene, was a gift from Prof. W. de Jong 
(University of Nijmegen, Nijmegen, The Netherlands). Plasmids were transformed into 
electro-competent Escherichia coli BL21 cells by electroporation using a GenePulser II system 
(Bio-Rad). 900 mL of LB stocks (1% tryptone, 0.5% yeast extract, 1% NaCl) that contained 
ampicillin (100 µg/mL) or kanamycin (50 µg/mL) were inoculated with 100 mL of overnight liquid 
cultures of BL21/pET23d-αA or BL21/pET24d-αB cells, respectively, and grown at 37 °C under 
vigorous shaking. The culture was induced with 10 mL of 50 mM isopropyl 
β-D-1-thiogalactopyranoside after reaching an optical density of ~0.5 at 600 nm, and further 
incubated for 3 h at 37 °C. Cells were harvested by centrifugation, and the expressed proteins were 
isolated using methods by Horwitz et al. [34]. Recombinant human αA and αB-crystallin were 
purified from the cell lysates using anion-exchange chromatography (HiPrep 16/10 DEAE FF 
column; GE Healthcare, Little Chalfont, United Kingdom), followed by size-exclusion 
chromatography (HiPrep 26/60 Sephacryl S-300 column; Amersham Biosciences, Uppsala, Sweden). 
 
Conjugation of Alexa350® to α-crystallin subunits 
 
Alexa350® fluorescent tag (410 Da) was conjugated to recombinant αA- and αB-crystallins using an 
Alexa Fluor® 350 Protein Labeling Kit (A10170, Molecular Probes, Carlsbad, California, USA), in 
accordance with the manufacturer’s instructions. Purified Alexa350®-conjugated αA- and 
αB-crystallins were measured using absorbance readings at 280 nm and 346 nm (A280 and A346) on a 
UVmini-1240 UV-VIS spectrophotometer (Shimadzu, Kyoto, Japan). The protein concentration and 
the degree of binding were determined using the following equations: 
 
[protein] = 
A280 - (A346 × 0.19)∈protein  × dilution 
(Eq. 1) 
 






Where 0.19 is a correction factor to account for absorption of Alexa350® at 280 nm, 19000 is the 
molar extinction coefficient for Alexa350® and ∈protein is the molar extinction coefficient for 
α-crystallin. 
 
Membrane binding measurements 
 
Alexa350®-conjugated αA- and αB-crystallins were incubated with bovine and human lens 
membranes in binding buffer at 37 °C for 6 h, based on protocols established previously [30]. Control 
assays were set up by replacing Alexa350®-α-crystallin subunits with unlabeled α-crystallin subunits. 
All assays were performed in triplicate. After incubation, samples were centrifuged at 14000 × g for 
30 minutes at 4 °C. The pellets were re-suspended in 30 μL of binding buffer and centrifuged again at 
14000 × g for 30 minutes at 4 °C. The supernatants from both centrifugations were pooled together. 
The resulting pellets, which contained the membrane, and bound Alexa350®-α-crystallin subunits, 
were re-suspended in a volume of binding buffer equivalent to that of the combined supernatants. 
Both the supernatants and the re-suspended pellets were transferred to 96-well polypropylene black 
microplates (Greiner Bio-One, Frickenhausen, Germany), and the fluorescence reading (F) of the 
samples was measured using a FLUOstar Optima multifunction microplate reader (BMG Labtech). 
The excitation and emission filters were set at 320-340 and 430-450 nm respectively. The degree of 
binding ( ) was determined by the following formula, where background fluorescence readings were 
obtained from control assays (using unlabeled α-crystallin): 
 
 = 
Fpellet – Fpellet background




The amount of α-crystallin subunits bound to the membranes was calculated by multiplying the total 
mass of Alexa350®-α-crystallin subunits used in the assay by the degree of binding ( ).  
 
Effect of endogenous crystallin peptides on the membrane binding of α-crystallin 
 
Peptide αB1-18 (Ac-MDIAIHHPWIRRPFFPFH) was purchased from Biomatik (Cambridge, Ontario, 
Canada) with sample purity ≥ 95%. Peptide γS167-178 (SPAVQSFRRIVE) was purchased from 
Peptide 2.0 (Chantilly, Virginia, USA) with sample purity of ≥ 91%. Peptides were solubilised in 
binding buffer to give a 4 g/L stock solution. Peptides were drawn from the stock solution and 
incubated with human lens membranes (80 μg) for 30 min at 37 °C. These were then incubated for 6 h 
at 37 °C in the presence of 24 μg of Alexa350®-conjugated αA- or αB-crystallin, or 24 μg of 
unlabeled αA- or αB-crystallin as negative controls. Binding assays were carried out as described 
previously. Peptide interaction data were analyzed using unpaired two-sample t-test. 
Results 
 
Analysis of proteins associated with lens fibre cell membranes 
 
Bovine lens membranes 
SDS-PAGE analysis of the urea-treated bovine (BU) membrane (Figure 1) showed that multiple 
proteins, ranging from 10 kDa to above 200 kDa, remain bound to the bovine lens membrane after the 
combined extractions of Tris- and urea-containing buffers. α-Crystallin subunits A and B (~20 kDa) 
were the predominant species detected, as shown by Western immunoblots (Figure 1). In contrast, 
the alkali-treated bovine (BA) lens membrane extract contained no protein that could be detected by 
Coomassie staining. 
 
Western immunoblots (Figure 1) revealed that both αA- and αB-crystallins (both ~20 kDa) were 
present in the BU and BA lens membranes, with a significant amount of higher molecular weight 
immuno-reactive protein also detected in the BU. Following further treatment of the membranes 
with alkali, α-crystallin subunits and a ~50 kDa αA species of protein remained (Figure 1). Of the 
two major intermediate filament proteins of the lens fibre cell cytoskeleton, intact filensin (115 kDa) 
and multiple cleavage products of filensin were detected only in the BU membrane, while vimentin 
(54 kDa) was present in both bovine lens membrane preparations (Figure 1).  
 
Human lens membranes 
SDS-PAGE analysis (Figure 2) revealed human lens membrane to be very different from bovine 
lens membrane. Three proteins of ~20 kDa, 22 kDa and 26 kDa, which correspond to 
αA/αB-crystallin, major intrinsic protein (MIP) 22 and MIP26 respectively, were present in all 
human lens membrane preparations (Figure 2). The urea-treated membrane preparations, 
particularly urea-treated nucleus (NU) membrane, showed noticeable smearing down the length of 
the gel. In addition, a low molecular weight (LMW) band which migrated with the dye-front was 
observed, which was particularly intense in the urea extracts. The presence of this band indicates that 
significant amounts of LMW peptides, likely derived from crystallins [35-37], remain tightly 
associated with the lens membranes after extraction with urea. 
 
Western immunoblots detected intact αA- and αB-crystallins (~20 kDa) in all human lens 
membrane preparations, even after the membranes had been stripped of the majority of extrinsic 
proteins with strong alkali solution (Figure 2). A diffuse band at ~43 kDa was also present in each of 
the αA-crystallin blots, with additional smearing between 70 kDa and 130 kDa, being particularly 
noticeable in the alkali-treated nuclear (NA) preparation. On the anti-αB-crystallin blots, extensive 
smearing was observed in the lanes of the urea-treated membranes, some of which may be 
attributed to non-specific immunoreactivity as described above. Interestingly, a variety of smaller 
αB-crystallin products less than 20 kDa remained bound to the lens membrane after urea-treatment 
(Figure 2). Most of the anti-αB reactive proteins were removed upon treatment with 0.1 M NaOH, 
except for some intense smearing from 90-150 kDa. Smearing was also observed on the anti-filensin 
blots of the urea-treated human lens membrane, while no filensin was detected in the alkali-treated 
membranes (Figure 2). Vimentin was only detected in the cortical human lens membrane preparations 
(Figure 2). 
 
Binding of α-crystallin subunits to lens membranes 
 
Purification of Alexa350®-α-crystallin subunits 
Recombinant human αA- and αB-crystallins were over-expressed in E. coli and conjugated to 
Alexa350®. On average, 0.56 ± 0.07 mol of Alexa350® was attached per mol of αA-crystallin, and 
0.44 ± 0.36 mol of Alexa350® per mol of αB-crystallin. 
 
Bovine lens membrane binding 
In order to compare the binding of α-crystallins to bovine and human lens membranes, we pre-labeled 
recombinant αA- and αB-crystallins with Alexa350®, whose excitation and emission characteristics 
are spectrally distinct from aromatic amino acids. Binding assays using BU and BA membranes 
displayed saturable binding behavior (Figure 3), which allowed us to calculate the membrane 
binding capacity from the asymptote of each curve (Table 1). The binding capacities for 
αA-crystallin were 28.1 ± 2.4 ng αA/μg BU membrane, and 19.5 ± 0.8 ng αA/μg BA membrane. 
The binding capacities for αB-crystallin were lower, being 19.1 ± 1.1 ng αB/μg BU membrane and 
6.0 ± 0.6 ng αB/μg BA membrane.  
 
Human lens membrane binding 
All of the assays using human lens membranes displayed saturable binding of the 
Alexa350-α-crystallins (Figure 4), and the binding capacity was greater, on the whole, than bovine 
lens membranes (Table 1). Comparing regions, a matched treatment analysis revealed that nuclear 
membrane had significantly greater binding capacity for the α-crystallins than cortical membrane 
(P<0.05). Matched region analysis indicated the difference in binding due to solvent treatment is 
less significant (P>0.1). For example, αA-crystallin was observed to bind NU and NA membrane 
with less than 20% difference in capacity, while CU and CA displayed almost identical 
αA-crystallin binding capacity. αB-Crystallin, however, exhibited significantly greater binding to 
the NU membrane than the NA membrane (208.0 ± 13.1 ng /μg compared with 67.0 ± 2.4 ng /μg). 
This result strongly suggests that proteins removed from the nuclear membrane by the alkali 
treatment have a much higher affinity for αB-crystallin than the extrinsic proteins of the cortex 
membrane.  
 
Membrane lipid analysis revealed no significant alteration in the ratios of the eight major classes 
(dihydrosphingomyelin, sphingomyelin, phosphatidylcholine, phosphatidylserine, ceramide, 
dihydroceramide, phosphatidylethanolamine and lysophosphatidylethanolamine) between the 
human membrane preparations used in these binding assays (Figure A1, Appendix I), demonstrating 
that membrane binding of α-crystallin was not influenced by changes to the proportion of individual 
membrane lipids. Human membrane preparations displayed no significant absorbance between 
380-500 nm (Figure A2, Appendix II), indicating there would be minimal interference with the 
fluorescent signal emitted by the Alexa350® dye. 
 
Effect of crystallin peptides on the membrane binding of α-crystallin subunits 
 
In a recent study, we reported that crystallin peptides αB1-18 and γS167-178 were present in human 
lenses across a broad age-range [36]. Santhoshkumar et al. [35] reported that peptide αB1-18 possessed 
anti-chaperone activity against α-crystallin, while peptide γS167-178 had little effect. Peptide αB1-18 
was found to significantly increase the amount of membrane-bound α-crystallin subunits in all but 
the CU membranes (Figure 5). In the case of αA-crystallin, the addition of peptide αB1-18 increased 
the binding by 59% (NU membrane), 72% (CA membrane) and 72% (NA membrane). Similar 
results were observed in binding assays using αB-crystallin, with the amount of membrane-bound 
αB-crystallin increasing by 61% (CA membrane) and 69% (NA membrane). However, peptide 
αB1-18 did not give rise to a significant increase in binding of αB-crystallin to the urea-treated 
membranes (Figure 5B), possibly due to the amount of endogenous αB-crystallin that is present on 
this membrane preparation (Figure 2). The addition of peptide γS167-178 had a negligible effect on the 




There is growing evidence that association with fibre cell membranes is an important process by 
which crystallins become water-insoluble in the lens [22, 25, 30]. This association may also 
contribute to the age-dependent loss of free α-crystallin [13-15]. In addition, large-scale binding of 
crystallin aggregates after middle age [22, 23] is implicated in the development of the lens barrier – a 
significant event in the human lens that is associated with subsequent cataractogenesis [24, 38, 39]. 
Building upon previous studies, where the membrane binding of α-crystallin was characterized using 
non-human lens tissues [26, 30, 40-44], here we determined the binding properties of α-crystallin to 
membranes isolated from both bovine and human lens tissues.  
 
αA- and αB-crystallins were the dominant membrane-bound proteins in the bovine lens after 
extraction with urea, whereas the human membrane also contained significant amounts of aquaporin 
0 (AQP0) (MIP26, MIP22), small peptides and, particularly in the nucleus, a complex mixture of 
cytoskeletal and crystallin proteins. Full-length αA- and αB-crystallins remained tightly associated 
with both the bovine and human lens membranes after extraction with 7 M urea, and remarkably, 
even after the alkali-treatment. The presence of α-crystallin after such vigorous treatment indicates 
that it is very tightly associated with, or even partially embedded in the fibre cell membrane. To our 
knowledge, this is the first evidence which suggests that α-crystallins may be an intrinsic 
component of the lens fibre cell membrane. Given the important role that α-crystallin has on the 
structural assembly of the beaded filaments [46, 47], the incorporation of α-crystallin into the fibre 
cell membrane structure may have functional significance regarding the stability and order of the 
lipid bilayer. Furthermore, fatty acid acylation, which confers membrane anchoring properties to 
proteins, and has been reported for lens AQP0 [45], may also contribute to the tight association 
between α-crystallin and the lens membrane, if α-crystallin subunits are acylated in a similar 
manner. 
 
We observed that the level of αB-, but not αA-crystallin, binding to the bovine and human 
membranes was influenced by the extent to which the membrane had been stripped of extrinsic 
proteins. This may be due to the fact that αB-crystallin is a more potent chaperone at physiological 
temperatures (37-40 °C) compared to αA-crystallin[48], and that membrane-bound proteins represent 
potential chaperone targets. As the alkali-treated membranes were largely stripped of this 
membrane-bound protein, the interacting targets for αB-crystallin decreased significantly, thus 
lower binding capacity was observed. These results suggest that the mechanisms by which αA- and 
αB-crystallins associate with the cellular membrane are different; αA-crystallin may interact 
exclusively with membrane phospholipids, thereby being unaffected by the presence of extrinsic 
proteins on the membrane, whereas these proteins may act as conduits for αB-crystallin to bind to 
the membrane. 
 
Membrane binding of both αA- and αB-crystallins was significantly increased in the presence of 
peptide αB1-18. It has previously been reported that when mixed with wild-type αB-crystallin, peptide 
αB1-18 increased the oligomeric size of the protein[49]. Thus, our results may reflect the fact that 
larger α-crystallin oligomers containing greater numbers of α-crystallin subunits are binding to the 
membrane. Considering that the emergence of this peptide in the lens nucleus [36] corresponds to the 
time when large-scale binding of α-crystallin to lens membrane is observed [22], this and other 
endogenous peptides [35, 36] may play a role in this process. 
  
Previous studies into membrane binding of α-crystallin have produced conflicting outcomes. For 
example, Ifeanyi et al. [42] found that the association of α-crystallin to membranes was mainly due 
to the αA subunit. In contrast, Cobb and Petrash [30] suggested that αA and αB subunits have 
similar binding capacities to lens membranes. Typically, membrane binding studies were performed 
using non-human lens membranes. As the membrane binding of α-crystallin is affected by the 
presence of membrane-bound proteins, and endogenous peptides, the use of non-human tissue does 
not appear to represent a useful model for the aging human lens. 
 
Recent studies have also shown that the lipid composition of human lens membrane differs 
considerably from that of other mammalian animals [32]. The levels of dihydrosphingomyelin and 
cholesterol are much higher in human lenses [32], and these hydrophobic components [50] could 
mimic the exposed hydrophobic residues on substrate proteins, with which α-crystallin is known to 
interact [51, 52]. Another characteristic of the human lens is that its phospholipids undergo major 
changes with age. The levels of glycerophospholipids in the nucleus of the lens decline steadily, 
such that by age 40, their content is negligible [53]. In contrast, the levels of ceramides and 
dihydroceramides in the lens nucleus increase approximately 100-fold during middle-age [53]. It is 
therefore possible that age-related changes to membrane phospholipids are influential in the binding 
of α-crystallin and the persistence of this versatile small heat-shock protein may also be an important 
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Figure 1: SDS-PAGE and Western immunoblot analysis of bovine lens membranes. The 
water-insoluble cell membrane pellets from bovine lens homogenates washed with 7 M urea (BU) 
and with 0.1 M NaOH (BA). Samples were analyzed by SDS-PAGE (100 μg of membrane per lane) 
and Western immunoblotting (20 μg of membrane per lane). Blots were probed using 
anti-αA-crystallin, anti-αB-crystallin, anti-filensin and anti-vimentin antibodies, as indicated. 
Molecular weight markers are on the left of the figure. 
 
Figure 2: SDS-PAGE and Western immunoblot analysis of human lens membranes. Isolated 
cortical and nuclear lens membranes were extracted with 7 M urea in Tris buffer (CU – cortex urea; 
NU – nucleus urea) and with 0.1 M NaOH (CA – cortex alkali; NA – nucleus alkali). Samples were 
analyzed by SDS-PAGE (100 μg of membrane per lane) and with Western immunoblotting (20 μg of 
membrane per lane). Blots were probed using anti-αA-crystallin, anti-αB-crystallin, anti-filensin and 
anti-vimentin antibodies, as indicated. Molecular weight markers are on the left of the figure. 
 
Figure 3: Binding of α-crystallin to bovine lens membrane preparations. Binding curves 
depicting the amount of bound Alexa350®-conjugated αA- (A) and αB-crystallin (B) per μg of 
urea-treated (●) or alkali-treated (▲) bovine lens membrane as a function of the free α-crystallin 
concentration. Bovine lens membranes (200 μg) were incubated with a mass range of 
Alexa350®-conjugated αA- and αB-crystallins, for 6 h at 37 °C. Results are the mean ± SEM (n = 3). 
 
Figure 4: Binding of α-crystallin to human lens membrane preparations. Binding curves 
depicting the amount of bound Alexa350®-conjugated αA- (A) and αB-crystallin (B) per μg of 
urea-treated cortical (●) and nuclear (▲) human lens membrane, or alkali-treated cortical (○) and 
nuclear (∆) human lens membrane as a function of the free α-crystallin concentration. Human lens 
membranes (80 μg) were incubated with a mass range of Alexa350®-conjugated αA- and 
αB-crystallins, for 6 h at 37 °C. Results are the mean ± SEM (n = 3). 
 
Figure 5: Effect of crystallin peptides on the binding of α-crystallin to human lens membranes. 
Graphs showing the amount (ng) of Alexa350®-conjugated αA- (A) or αB-crystallin (B) bound per 
μg of human lens membrane in the presence of crystallin peptides. Human lens membranes (80 μg) 
were mixed with either 48 μg of peptide αB1-18 (solid bars), 48 μg of peptide γS167-178 (dotted bars), 
or with binding buffer only (horizontal line bars), for 30 min at 37 °C. Alexa350®-conjugated αA- or 
αB-crystallin (24 μg) was then added and the mixtures were incubated for 6 h at 37 °C. Results are 
the mean ± SEM (n = 3). *P<0.05, **P<0.01, ***P<0.001 compared with assays performed with 












αA binding capacity 
(ng/μg membrane) 
αB binding capacity 
(ng/μg membrane) 
BU 28.1 ± 2.4 19.1 ± 1.1 
BA 19.5 ± 0.8 6.0 ± 0.6 
CU 31.5 ± 2.0 54.3 ± 4.2 
CA 33.4 ± 2.8 31.6 ± 1.8 
NU 95.4 ± 4.2 208.0 ± 13.1 
NA 78.5 ± 2.0 67.0 ± 2.4 
 
Abbreviations used: BU – urea-treated bovine membrane; BA – alkali-treated bovine membrane; 
CU – urea-treated human cortical membrane; CA – alkali-treated human cortical membrane; NU – 
urea-treated human nuclear membrane; NA – alkali-treated human nuclear membrane. 
 
